EpiCast Report: Seasonal Influenza – Epidemiology Forecast to 2025
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses resulting in mild to severe influenza-like illness. Seasonal influenza affects persons of all ages. Each year, between 5% and 15% of the world's population is affected by seasonal influenza (WHO, 2013). Complications of influenza include pneumonia, bronchitis, ear infections, sinus infections, and worsening of chronic medical conditions such as congestive heart failure, asthma, or diabetes. Vaccination has been shown to reduce influenza morbidity and mortality and high economic burden associated with influenza illness.
GlobalData epidemiologists identified country-specific population-based studies and government-collated surveillance data to build the influenza forecast, and utilized appropriate proxy data where applicable. Moreover, clinically relevant segmentations are provided for diagnosed incident cases of seasonal influenza, including influenza-like illness (ILI) cases, lab confirmed cases, hospitalized cases, and averted cases. Lastly, uniform diagnostic criteria are utilized for all segmentations across the 7MM using ICD-10 codes J09-J10, and seasonal versus calendar year influenza cases were reconciled, for example, by applying rates from the 2007-2008 influenza season to the 2007 calendar year population.
In the 7MM, GlobalData epidemiologists forecast that the seasonal influenza vaccination coverage will increase from 323,457,073 people in 2015 to 344,202,999 people in 2025, at an Annual Growth Rate (AGR) of 0.64%. The US will have the largest population vaccinated for seasonal influenza among the 7MM throughout the forecast period, while Spain will have the lowest. In the 7MM, GlobalData epidemiologists forecast that the diagnosed outpatient ILI incident cases will increase from 38,432,598 cases in 2015 to 38,686,403 cases in 2025, at an AGR of 0.07%. GlobalData epidemiologists forecast that the influenza cases averted by seasonal influenza vaccinations will increase from 1,801,663 cases in 2015 to 1,858,033 cases in 2025.
Scope
The Seasonal Influenza EpiCast Report and EpiCast Model provides an overview of the risk factors, comorbidities, and the global and historical trends for seasonal influenza in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of seasonal influenza segmented by age and sex in the 7MM. Moreover, clinically relevant segmentations are provided for diagnosed incident cases of seasonal influenza, including influenza-like illness (ILI) cases, lab confirmed cases, hospitalized cases, and averted cases. In addition, the report also includes the number of individuals who received the influenza vaccination in the 7MM. For all the 7MM, diagnosed incident cases are segmented by age (0–4 years, 5–17 years, 18–64 years, and =65 years) and sex.
The seasonal influenza epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.